December 22nd 2025
Abbott's Volt PFA System gains FDA approval, offering a new minimally invasive treatment for atrial fibrillation, enhancing patient care options.
Effective BP Reduction Achieved via Hypertension Remote Care Program During Lockdown
November 10th 2021AHA Scientific Sessions 2021: Blood pressure reductions to clinical targets were achieved by patients with sustained hypertension through a remote health care delivery program during the COVID-19 pandemic.
Metabolically Healthy Obesity May Increase Risk of Heart Failure, but Not Heart Attack or Stroke
October 5th 2021EASD 2021: Patients with metabolically healthy obesity are nearly 33% more likely to develop heart failure and atrial fibrillation than healthy persons of normal weight, suggests new analysis.